BlackRock Investment Management’s OncoSec Medical Incorporated ONCS Stock Holding History

BlackRock Investment Management’s Portfolio ONCS Stock Details ONCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$3K	Hold	12	–	–	﹤0.01%	3854
2016 Q3	$5K	Hold	12	–	–	﹤0.01%	3797
2016 Q2	$4K	Hold	12	–	–	﹤0.01%	3908
2016 Q1	$7K	Hold	12	–	–	﹤0.01%	3754
2015 Q4	$6K	Hold	12	–	–	﹤0.01%	3842
2015 Q3	$14K	Buy	12 +3	+33%	+$3.93K	﹤0.01%	3564
2015 Q2	$13K	Buy	+9	New	+$13.5K	﹤0.01%	3629

Other funds holding ONCS

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return

BlackRock Investment Management's ONCS Position: Q4 2016 in Review

BlackRock Investment Management held its OncoSec Medical Incorporated (ONCS) position steady in Q4 2016 at 12 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #3854.

BlackRock Investment Management first reported a position in ONCS in Q2 2015 and has held it in 7 quarters since. The position peaked at $14K in Q3 2015. 26 funds tracked by Wall St. Rank hold ONCS as of Q4 2016.

BlackRock Investment Management held 12 shares of OncoSec Medical Incorporated worth $3K as of Q4 2016.
BlackRock Investment Management left its OncoSec Medical Incorporated share count unchanged in Q4 2016.
OncoSec Medical Incorporated made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3854 holding.
BlackRock Investment Management first reported a position in OncoSec Medical Incorporated in Q2 2015 and has held it in 7 quarters since.
BlackRock Investment Management's OncoSec Medical Incorporated position peaked at $14K in Q3 2015.
26 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.